Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

SARS-CoV-2 protein subunit vaccines are currently being evaluated by multiple manufacturers to address the global vaccine equity gap, and need for low-cost, easy to scale, safe, and effective COVID-19 vaccines. In this paper, we report on the generation of the receptor-binding domain RBD203-N1 yeast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Hsiang, Pollet, Jeroen, Strych, Ulrich, Lee, Jungsoon, Liu, Zhuyun, Kundu, Rakhi Tyagi, Versteeg, Leroy, Villar, Maria Jose, Adhikari, Rakesh, Wei, Junfei, Poveda, Cristina, Keegan, Brian, Bailey, Aaron Oakley, Chen, Yi-Lin, Gillespie, Portia M., Kimata, Jason T., Zhan, Bin, Hotez, Peter J., Bottazzi, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529586/
https://www.ncbi.nlm.nih.gov/pubmed/34688919
http://dx.doi.org/10.1016/j.pep.2021.106003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529586/
https://www.ncbi.nlm.nih.gov/pubmed/34688919
http://dx.doi.org/10.1016/j.pep.2021.106003

Ejemplares similares